Expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human breast cancer
β Scribed by Masakazu Toi; Seigo Hosnina; Tadaaki Taniguchi; Yutaka Yamamoto; Hideo Ishitsuka; Takeshi Tominaga
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- French
- Weight
- 588 KB
- Volume
- 64
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
β¦ Synopsis
We have investigated the expression of platelet-derived endothelial-cell growth factorkhymidine phosphorylase (PD-ECGF/dThdPase) in human breast-cancer tissues by the immunocytochemical method using anti-PD-ECGF/ dThdPase monoclonal antibody. Out of I00 invasive-ductal-carcinoma tissue samples, 39 (39%) were evaluated as PD-ECGF/dThdPasepositive. The expression of PD-ECGF/dThdPase was identified mainly in the cytoplasma of tumor cells. The expression of PD-ECGF/dThdPase was significantly associated with the microvessel density assessed by immunostaining to factor-VIIIrelated-antigen (p < 0.05). However, there was no correlation between expression of PD-ECGF/dThdPase and menopausal status, tumor size, axillary lymph-node metastases, hormonereceptor status, epidermal-growth-factor receptor, or erb-B-2protein and p53-protein expression. We suggest that expression of PD-ECGF/dThdPase plays an important role in the promotion of angiogenesis in human breast cancer.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND Thymidine phosphorylase (TP) is identical to plateletβderived endothelial cell growth factor (PDECGF) and has angiogenic activity. Little is known about the significance of TP/PDECGF activity in patients with renal cell carcinoma (RCC). The authors examined the enzymatic
## Background: Angiogenesis is a prerequisite to cancer growth and metastasis and is induced by a variety of angiogenic factors, including platelet-derived endothelial cell growth factor (pdecgf). the authors investigated the expression of pdecgf in 58 initial primary bladder carcinomas. ## Method